Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/22/2020 05/26/2020 05/27/2020 05/28/2020 05/29/2020 Date
218.81(c) 217.01(c) 216.35(c) 222.15(c) 224.72(c) Last
730 965 981 423 1 069 861 1 166 732 1 590 454 Volume
+0.14% -0.82% -0.30% +2.68% +1.16% Change
More quotes
Financials (USD)
Sales 2020 4 254 M - -
Net income 2020 1 039 M - -
Net cash position 2020 823 M - -
P/E ratio 2020 46,8x
Yield 2020 -
Sales 2021 5 069 M - -
Net income 2021 1 246 M - -
Net cash position 2021 1 677 M - -
P/E ratio 2021 37,3x
Yield 2021 -
Capitalization 46 417 M 46 417 M -
EV / Sales 2020 10,7x
EV / Sales 2021 8,83x
Nbr of Employees 13 900
Free-Float 93,9%
More Financials
Company
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - hemodynamic monitoring systems (61.4%); - heart valves and surgery products (20.4%); - other (18.1%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the... 
More about the company
Surperformance© ratings of Edwards Lifesciences Corpo
Trading Rating : Investor Rating :
More Ratings
Latest news on EDWARDS LIFESCIENCES CORPO
05/18EDWARDS LIFESCIENCES : PASCAL Transcatheter Valve Repair System Receives Europea..
PR
05/08EDWARDS LIFESCIENCES CORP : Amendments to Articles of Inc. or Bylaws; Change in ..
AQ
05/05EDWARDS LIFESCIENCES : Announces May 2020 Investor Conference Schedule
PR
05/04UNITED PARCEL SERVICE : UPS Supports Edwards Lifesciences' Distribution Of Criti..
AQ
04/28EDWARDS LIFESCIENCES : Management's Discussion and Analysis of Financial Conditi..
AQ
04/27EDWARDS LIFESCIENCES : ' HemoSphere Platform Gets Health Canada Indication to Tr..
DJ
04/27EDWARDS LIFESCIENCES : ' HemoSphere Platform Receives Expanded Use Indication Fr..
AQ
04/24Hertz; J.C. Penney fall; Edwards Lifesciences, WWE rise
AQ
04/24EDWARDS LIFESCIENCES : Thinking about trading options or stock in Comcast, CVS H..
PR
04/24EDWARDS LIFESCIENCES : Patents And The Public Interest – When Should A Fin..
AQ
04/23EDWARDS LIFESCIENCES : Lowers Financial Targets
DJ
04/23EDWARDS LIFESCIENCES : Beats Analysts' Targets for 1Q
DJ
04/23EDWARDS LIFESCIENCES CORP : Results of Operations and Financial Condition, Finan..
AQ
04/23EDWARDS LIFESCIENCES : 1Q Earnings Snapshot
AQ
04/23EDWARDS LIFESCIENCES CORPORATION : 1st quarter results
CO
More news
News in other languages on EDWARDS LIFESCIENCES CORPO
05/18EDWARDS LIFESCIENCES : PASCAL Transcatheter Valve Repair System Receives Europea..
05/08EDWARDS LIFESCIENCES CORP : Amendments to Articles of Inc. or Bylaws; Change in ..
05/05EDWARDS LIFESCIENCES : Announces May 2020 Investor Conference Schedule
05/04UNITED PARCEL SERVICE : UPS Supports Edwards Lifesciences' Distribution Of Criti..
04/28EDWARDS LIFESCIENCES : Management's Discussion and Analysis of Financial Conditi..
More news
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPO
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 239,35 $
Last Close Price 224,72 $
Spread / Highest target 24,6%
Spread / Average Target 6,51%
Spread / Lowest Target -31,0%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
John P. McGrath Vice President-Quality, Regulatory & Clinical
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION-3.67%46 417
THERMO FISHER SCIENTIFIC5.50%135 366
DANAHER CORPORATION4.76%115 930
INTUITIVE SURGICAL, INC.-3.17%66 751
ILLUMINA, INC.9.67%54 832
BOSTON SCIENTIFIC CORPORATION-17.14%53 391